ETF Battles: Which Biotech Stock ETF Is The Better Choice? - It's IBB Vs. XBI
Video By:
Rick Ristov
Watch
Thursday, December 23, 2021 6:26 AM EST
It's ETF Battles time, and in today's episode we'll be comparing the two biotech giants iShares Biotechnology ETF (IBB) Vs. SPDR S&P ETF (XBI).
Omicron Could Push Up Pfizer’s Share Price By 10% In The Short Term
Article By:
Rick Ristov
Read
Wednesday, December 22, 2021 8:02 AM EST
How the new Omicron Covid variant affects the Pharma/Biotech market and what does this mean for Pfizer/Moderna?
In this article: PFE
High Drug Prices And The Refusal To Talk Seriously About Debt And Deficits
Article By:
Rick Ristov
Read
Thursday, October 28, 2021 9:17 AM EST
Reporters and politicians have been screaming about our debt and deficits in recent weeks, as the Democrats try to steer their public investment package through the senators from Arizona and West Virginia.
Cempra Poised To Join Antibacterial Drug Acquisition Rumor Buzz With Upcoming Data Release
Article By:
Scott Matusow
Read
Monday, November 24, 2014 12:28 PM EST
Cempra Pharmaceuticals expects top-line data release for community acquired bacterial pneumonia by the end of Q1'15.
With the very recent Tetraphase acquisition rumor buzz, Cempra is certain to join the acquisition buzz fray if its data release proves positive.
E Going Green And Saving Green
Article By:
Vivian Lewis
Read
Saturday, November 22, 2014 8:39 AM EST
Today we consider a way to play cheap fuel prices which directly offsets one of our oil plays. Plus, we plan to take the train. And we report on global energy, pharma and food stock happenings.
E Special Report: Benitec Biopharma Ltd.
Article By:
Vivian Lewis
Read
Thursday, November 20, 2014 8:41 AM EST
This special report is about Benitec, a stock we recommend, after I spent the morning at its US Investor Day.
In this article: BTEBY
AGIO Hits Record Level On Impressive Clinical Data For Leukemia Drug
Article By:
BioMedReports
Read
Thursday, November 20, 2014 3:21 AM EST
Shares of Agios Pharmaceuticals Inc. posted its biggest single day rally on Wednesday since 26th September. The stock is up a whopping 15% to $96.25 after hitting an all time high of $96.88 earlier in the session.
In this article: AGIO
E Merrimack Receives Fast Track For Pancreatic Cancer Drug
Article By:
Terry Chrisomalis
Read
Wednesday, November 19, 2014 4:29 PM EST
The reason the FDA gave MACK Fast Track approval is because there are no current therapies for pancreatic cancer -- the drug meets an unmet medical need.
Health Care REIT Completes HealthLease Transaction
Article By:
Business Wire
Read
Wednesday, November 19, 2014 12:00 PM EST
Health Care REIT, Inc. announced today the completion of the previously announced acquisition of HealthLease Properties REIT (“HealthLease”).
In this article: HCN
CytRx Announces Partial Clinical Hold On Main Drug' Big Buying Opportunity For Investors
Article By:
Terry Chrisomalis
Read
Tuesday, November 18, 2014 2:36 PM EST
Aldoxorubicin receives a partial clinical hold from the FDA.
In this article: CYTR
